Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction

Keattiyoat Wattanakit1, Josef Coresh, Paul Muntner

  • 1Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55454-1015, USA.

Insights

Chronic kidney disease (CKD) is not a coronary heart disease (CHD) risk equivalent to a prior myocardial infarction (MI). This study found CKD confers lower CHD risk in a general, nondiabetic population.

Area of Science:

  • Cardiology
  • Nephrology
  • Epidemiology

Background:

  • Coronary heart disease (CHD) risk stratification is crucial for guiding cholesterol treatment.
  • The equivalence of chronic kidney disease (CKD) risk to established coronary heart disease (CHD) risk factors, such as prior myocardial infarction (MI), remains unclear.
  • Understanding these risk equivalencies is vital for effective cardiovascular disease (CVD) prevention strategies.

Purpose of the Study:

  • To determine if chronic kidney disease (CKD) should be classified as a coronary heart disease (CHD) risk equivalent for cholesterol management.
  • To compare the risk of CHD events and cardiovascular disease (CVD) mortality in patients with CKD versus those with a prior myocardial infarction (MI).

Main Methods:

  • Utilized data from the Atherosclerosis Risk in Communities (ARIC) study.
  • Nondiabetic participants were categorized by kidney function (estimated glomerular filtration rate) and history of prior myocardial infarction (MI).
  • Compared rates and relative risks (RR) of CHD events and CVD mortality over 10 years across defined participant groups.

Main Results:

  • Among 12,243 participants, 271 had stage 3 CKD.
  • After adjusting for confounders, individuals with CKD but no prior MI had significantly lower RR for CHD events (RR=0.44) and CVD mortality (RR=0.46) compared to those with prior MI and no CKD.
  • CHD incidence and CVD mortality rates were highest in individuals with both CKD and prior MI.

Conclusions:

  • Stage 3 CKD is associated with a lower coronary heart disease (CHD) risk than a prior myocardial infarction (MI).
  • In a middle-aged, general, nondiabetic population, CKD is not equivalent to prior MI in terms of CHD risk.
  • Findings suggest differential risk stratification may be appropriate for patients with CKD regarding cholesterol treatment.
Abstract

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...